Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials. LATEST IPOS AND… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3990033/-Opening-Day-Obesity-drug-developer-BioAge-makes-Nasdaq-debut)